Business Description
BioAtla Inc
NAICS : 541714
SIC : 2833
ISIN : US09077B1044
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 45.31 | |||||
Equity-to-Asset | 0.59 | |||||
Debt-to-Equity | 0.04 | |||||
Debt-to-EBITDA | -0.02 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 12.2 | |||||
3-Year EPS without NRI Growth Rate | 1 | |||||
3-Year FCF Growth Rate | 20.8 | |||||
3-Year Book Growth Rate | -38.2 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 35.76 | |||||
9-Day RSI | 35.24 | |||||
14-Day RSI | 39.26 | |||||
6-1 Month Momentum % | 79.85 | |||||
12-1 Month Momentum % | -30.35 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.11 | |||||
Quick Ratio | 4.11 | |||||
Cash Ratio | 3.93 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -12.6 | |||||
Shareholder Yield % | 1.31 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -98.51 | |||||
ROA % | -70.07 | |||||
ROIC % | -1511.26 | |||||
ROC (Joel Greenblatt) % | -3117.03 | |||||
ROCE % | -88.35 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 1.53 | |||||
Price-to-Tangible-Book | 1.53 | |||||
EV-to-EBIT | -0.03 | |||||
EV-to-Forward-EBIT | -0.01 | |||||
EV-to-EBITDA | -0.03 | |||||
EV-to-Forward-EBITDA | -0.02 | |||||
EV-to-FCF | -0.04 | |||||
Price-to-Net-Current-Asset-Value | 1.61 | |||||
Price-to-Net-Cash | 1.73 | |||||
Earnings Yield (Greenblatt) % | -3333.33 | |||||
FCF Yield % | -96.21 |